All In Biotech

Free tool

FAERS Monitor: Maxitrol

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050065 or its brand name (Maxitrol, Dexamethasone, Neomycin Sulfate, Polymyxin B Sulfate). Reports on generic versions are filed under their own applications.

Reports

1,087

Serious

663

61% of reports

Hospitalization

229

Death reported

50

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • eye pain92
  • eye irritation80
  • vision blurred70
  • ocular hyperaemia60
  • off label use58
  • pain52
  • visual impairment52
  • drug ineffective48
  • headache46
  • fatigue42
  • dyspnoea39
  • condition aggravated37
  • nausea36
  • anxiety35
  • intraocular pressure increased35

Reports by year received

View as table
YearReports
20046
20052
20066
200714
20087
200912
201021
20115
201221
201330
201433
201544
2016104
201756
201889
201994
2020106
202158
202277
202395
202477
202577
202653

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,072 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
intraocular pressure increasedSignal3553.138.31,735
eye painSignal9231.626.02,699
eye irritationSignal8026.921.81,974
ocular hyperaemiaSignal6024.519.11,330
vision blurredSignal709.97.9552
visual impairmentSignal528.16.2319
anxietySignal352.41.727
condition aggravatedSignal372.41.728
pain521.61.313
headache461.41.15
dyspnoea391.31.03
off label use581.31.03
fatigue421.00.80
nausea360.90.60
drug ineffective480.70.56

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.